These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16249688)

  • 1. The practicality and need for genetic testing for malignant hyperthermia.
    Brandom BW; Muldoon SM
    Anesthesiology; 2005 Nov; 103(5):1100; author reply 1101. PubMed ID: 16249688
    [No Abstract]   [Full Text] [Related]  

  • 2. Difficult diagnosis of malignant hyperthermia during laparoscopic surgery.
    Freiermuth D; Poblete B; Singer M; Konrad CJ; Girard T
    Eur J Anaesthesiol; 2013 Oct; 30(10):635-8. PubMed ID: 23736090
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic testing for malignant hyperthermia in North America.
    Nelson TE; Rosenberg H; Muldoon SM
    Anesthesiology; 2004 Feb; 100(2):212-4. PubMed ID: 14739790
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomics of inhalational anesthetic agents.
    Nair AS
    Med Gas Res; 2019; 9(1):52-53. PubMed ID: 30950419
    [No Abstract]   [Full Text] [Related]  

  • 5. A genetic mystery in malignant hyperthermia 'solved'?
    Schiemann AH; Bjorksten AR; Gillies RL; Hockey BM; Ball C; Pollock N; Bulger T; Stowell KM
    Br J Anaesth; 2018 Sep; 121(3):681-682. PubMed ID: 30115273
    [No Abstract]   [Full Text] [Related]  

  • 6. XXIVth Annual Meeting of the European Malignant Hyperthermia Group.
    Brandom BW; Muldoon SM
    Anesthesiology; 2005 Dec; 103(6):1324. PubMed ID: 16306761
    [No Abstract]   [Full Text] [Related]  

  • 7. Suspected malignant hyperthermia during sevoflurane anesthesia.
    Hsu SC; Huang WT; Yeh HM; Hsieh AY
    J Chin Med Assoc; 2007 Nov; 70(11):507-10. PubMed ID: 18063506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia genetic testing in North America Working Group Meeting. Bethesda, Maryland. September 4-5, 2002.
    Sei Y; Sambuughin N; Muldoon S
    Anesthesiology; 2004 Feb; 100(2):464-5. PubMed ID: 14870754
    [No Abstract]   [Full Text] [Related]  

  • 9. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
    Brandom BW; Muldoon SM
    Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal diagnosis of malignant hyperthermia susceptibility.
    Girard T; Jöhr M; Schaefer C; Urwyler A
    Anesthesiology; 2006 Jun; 104(6):1353-4. PubMed ID: 16732128
    [No Abstract]   [Full Text] [Related]  

  • 11. [Malignant hyperthermia].
    Yuge O; Mukaida K
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():635-42. PubMed ID: 11838177
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed onset of malignant hyperthermia without creatine kinase elevation in a geriatric, ryanodine receptor type 1 gene compound heterozygous patient.
    Newmark JL; Voelkel M; Brandom BW; Wu J
    Anesthesiology; 2007 Aug; 107(2):350-3. PubMed ID: 17667581
    [No Abstract]   [Full Text] [Related]  

  • 13. Continued progress in understanding the molecular genetics of malignant hyperthermia.
    Rosenberg H
    Can J Anaesth; 2011 Jun; 58(6):489-93. PubMed ID: 21455644
    [No Abstract]   [Full Text] [Related]  

  • 14. Sudden death due to malignant hyperthermia with a mutation of RYR1: autopsy, morphology and genetic analysis.
    Li W; Zhang L; Liang Y; Tong F; Zhou Y
    Forensic Sci Med Pathol; 2017 Dec; 13(4):444-449. PubMed ID: 29101530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out of a cell into this darkened space.
    Parness J; Hogan KJ
    Anesth Analg; 2010 Jul; 111(1):13-6. PubMed ID: 20576962
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.
    Yang T; Riehl J; Esteve E; Matthaei KI; Goth S; Allen PD; Pessah IN; Lopez JR
    Anesthesiology; 2006 Dec; 105(6):1164-75. PubMed ID: 17122579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic testing to diagnose malignant hyperthermia susceptibility.
    Girard T; Litman RS
    J Clin Anesth; 2008 May; 20(3):161-3. PubMed ID: 18502356
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.
    Gonsalves SG; Dirksen RT; Sangkuhl K; Pulk R; Alvarellos M; Vo T; Hikino K; Roden D; Klein TE; Poler SM; Patel S; Caudle KE; Gordon R; Brandom B; Biesecker LG
    Clin Pharmacol Ther; 2019 Jun; 105(6):1338-1344. PubMed ID: 30499100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in vitro contracture test.
    Roux-Buisson N; Monnier N; Sagui E; Abriat A; Brosset C; Bendahan D; Kozak-Ribbens G; Gazzola S; Quesada JL; Foutrier-Morello C; Rendu J; Figarella-Branger D; Cozonne P; Aubert M; Bourdon L; Lunardi J; Fauré J
    Br J Anaesth; 2016 Apr; 116(4):566-8. PubMed ID: 26994242
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.
    Beam TA; Loudermilk EF; Kisor DF
    Physiol Genomics; 2017 Feb; 49(2):81-87. PubMed ID: 28011884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.